Navigation Links
Memory Pharmaceuticals Highlights Progress with Key Programs at its R&D Day
Date:5/16/2008

MONTVALE, N.J., May 16 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals Corp. (Nasdaq: MEMY) today announced progress with several key development programs at its R&D Day meeting with the investment community. The Company reported new clinical data for MEM 1414, its lead PDE4 inhibitor, demonstrating the compound's CNS activity in humans. In addition, the Company has nominated MEM 68626 as the lead development candidate from its 5-HT6 antagonist program, and separately confirmed its 2008 development goals for its pipeline.

"We are extremely excited about the progress we have made in advancing our programs," said Vaughn M. Kailian, President and Chief Executive Officer of Memory Pharmaceuticals. "MEM 1414 produced a robust CNS signal in a human quantitative EEG study. In addition, using human whole blood assays, we have identified plasma concentrations required for anti-inflammatory activity. These data, combined with previous pharmacokinetic and safety data obtained in Phase 1 clinical trials for MEM 1414, will guide dosing for a proof-of-concept trial in either a cognition or respiratory indication, which we expect to initiate by the end of 2008."

Mr. Kailian continued, "Further, we are pleased to report that we have nominated MEM 68626 as the lead compound in our 5-HT6 antagonist program. MEM 68626 has demonstrated strong preclinical efficacy data in cognition and has a favorable safety and pharmacokinetic profile, which we believe offers advantages over other compounds in development. We look forward to advancing MEM 68626 into the clinic this year."

MEM 1414 - Potential in Cognition and Inflammation

Memory Pharmaceuticals reported the results of a clinical study of MEM 1414 on quantitative EEG (qEEG), a bio
'/>"/>

SOURCE Memory Pharmaceuticals Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Experimental Drug Ketasyn(TM) Improves Memory in Age-Associated Memory Impairment Study
2. Memory Pharmaceuticals Commences Phase 1 Clinical Program for R4996/MEM 63908
3. Memory Pharmaceuticals Announces Results for Phase 2a Trial of MEM 1003 in Alzheimers Disease
4. Experts Call for Widespread Use of Memory Screenings and Emphasize Value of Early Detection of Dementia
5. Memory Pharmaceuticals & Roche Expand Development Program for MEM 3454 in Schizophrenia
6. Memory Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Financial Results
7. How Big Is Your Brain? Its Size May Protect You from Memory Loss
8. Medivations Dimebon(TM) Significantly Improved Thinking and Memory in Alzheimers Disease Patients Over One Year
9. Roche Exercises its Option to Further Develop and Commercialize Memory Pharmaceuticals Nicotinic Alpha-7 Agonist, MEM 3454
10. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
11. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... -- Zipnosis, the first virtual care solution to empower health care ... branded virtual care service line, announced an agreement with ... currently in use. ... As health systems consider how ... of providing their own branded online care for common medical ...
(Date:7/28/2015)... 28, 2015 ANI Pharmaceuticals, Inc. (NASDAQ: ... release its second quarter and year-to-date 2015 financial results ... the U.S. financial markets. The earnings press release will ... Company,s website, www.anipharmaceuticals.com . Arthur ... Charlotte C. Arnold , Vice President and Chief ...
(Date:7/28/2015)... , July 28, 2015 Egalet ... integrated specialty pharmaceutical company focused on developing, manufacturing ... pricing of an underwritten public offering of 6,666,667 ... offering price of $11.25 per share. The gross ... to be approximately $75 million, before deducting the ...
Breaking Medicine Technology:Zipnosis Announces Group Health to use Virtual Care Service Line 2Zipnosis Announces Group Health to use Virtual Care Service Line 3ANI Pharmaceuticals Schedules Conference Call for Second Quarter and Year-to-Date 2015 Financial Results 2Egalet Announces Pricing of Public Offering of Common Stock 2Egalet Announces Pricing of Public Offering of Common Stock 3Egalet Announces Pricing of Public Offering of Common Stock 4
... YORK, Nov. 12 A new study being,published in ... the,question, what causes Parkinson,s disease?, One of the ... is what causes the sensitive cells in the brain ... been especially difficult,because there are two nearly identical types ...
... 12 Surgeons,at the University of Rochester Medical ... converted to an endovascular simulator,(ANGIO Mentor(TM), Simbionix US) ... the simulation improved the operative flow,increased patient safety ... fluoroscopy time and the amount of contrast used, ...
Cached Medicine Technology:A Window Into Parkinson's Disease 2Vascular Surgeons Agree: Case Rehearsal Improves Outcomes 2
(Date:7/28/2015)... ... July 28, 2015 , ... Dr. Edward Buckingham ... Dr. Sudeep Roy in July 2016. Coming to Austin from Philadelphia, Dr. Roy ... The twelve-month long training is facilitated annually by the American Academy of Facial ...
(Date:7/28/2015)... ... 2015 , ... Healthline , a provider of intelligent health information and ... perspectives on digital health . The survey, which was conducted among 3,679 ... health, level of trust in the security of digital health tools, impact of these ...
(Date:7/28/2015)... (PRWEB) , ... July 28, 2015 , ... ... the first fitness studio to measure and produce health outcomes associated with its ... , Focusing on a small group pre-post study, conducted in early 2015, ...
(Date:7/28/2015)... ... , ... Egg freezing is becoming an increasingly popular option for ... Dr. Michael Kettel explained in an article from the San Diego ... previous generations who had to make choices between their fertility and their career or ...
(Date:7/28/2015)... Palm Beach, FL (PRWEB) , ... July 28, 2015 , ... ... legislation when state officials refused to schedule the hearing of proposed bills and laws ... highest rates of new infections to date. Some vigilante ministers are continuing to hand ...
Breaking Medicine News(10 mins):Health News:Buckingham Center for Facial Plastic Surgery Welcomes Fellow 2Health News:Buckingham Center for Facial Plastic Surgery Welcomes Fellow 3Health News:Consumers Concerned About Privacy of Personal Health Data on Wearables and Mobile Apps, According to New Healthline Survey 2Health News:Consumers Concerned About Privacy of Personal Health Data on Wearables and Mobile Apps, According to New Healthline Survey 3Health News:Consumers Concerned About Privacy of Personal Health Data on Wearables and Mobile Apps, According to New Healthline Survey 4Health News:Consumers Concerned About Privacy of Personal Health Data on Wearables and Mobile Apps, According to New Healthline Survey 5Health News:opaJUMP Launches First Case Study in Thyroid Health: How Rebounding Helped One Woman Stabilize Her Thyroid in Seven Weeks 2Health News:opaJUMP Launches First Case Study in Thyroid Health: How Rebounding Helped One Woman Stabilize Her Thyroid in Seven Weeks 3Health News:opaJUMP Launches First Case Study in Thyroid Health: How Rebounding Helped One Woman Stabilize Her Thyroid in Seven Weeks 4Health News:opaJUMP Launches First Case Study in Thyroid Health: How Rebounding Helped One Woman Stabilize Her Thyroid in Seven Weeks 5Health News:opaJUMP Launches First Case Study in Thyroid Health: How Rebounding Helped One Woman Stabilize Her Thyroid in Seven Weeks 6Health News:opaJUMP Launches First Case Study in Thyroid Health: How Rebounding Helped One Woman Stabilize Her Thyroid in Seven Weeks 7Health News:Dr. Michael Kettel of San Diego Fertilty Center Interviewed by the San Diego Union-Tribune on Egg Freezing 2Health News:Dr. Michael Kettel of San Diego Fertilty Center Interviewed by the San Diego Union-Tribune on Egg Freezing 3Health News:Needle Exchange Programs Are Delayed in Legislation, West Palm Beach Drug Rehab Comments 2Health News:Needle Exchange Programs Are Delayed in Legislation, West Palm Beach Drug Rehab Comments 3
... Researchers from the University of California, San Diego; ... of California, San Francisco; and the University of South ... to childhood obesity, but also to hypertension in children, ... issue of the American Journal of Preventive Medicine. , ...
... ARLINGTON, Va., Oct. 29 The holidays are ... and homes are,brightened with the glitter of decorations. ... often overlooked. As decorations go up and,households entertain ... risk to fire and electrocution. This holiday safety ...
... Merge Technologies,Incorporated, doing business as "Merge Healthcare" ... leading medical imaging software and services provider,announced that, ... financial statements, the Company currently expects to file, ... audited financial statements for,the years ended December 31, ...
... money totaling $30,000,has been announced for the inaugural Mississippi Blues Marathon and,Half-Marathon, scheduled for January 5, 2008. Prize money ... Male Female 1st Place ... 3,000 3rd Place 2,000 ... 1,500 5th Place 1,000 1,000, Wheelchair ...
... California, October 29 IsoTis, Inc.,(NASDAQ: ISOT ... the special meeting of stockholders re-convened earlier today, ... Integra,LifeSciences Holdings Corporation (NASDAQ: IART ) ("Integra") ... as of August 6, 2007. The acquisition ...
... October 29, 2007 — For some epilepsy patients, the ... the seizures. One pressing concern is the cognitive impairment ... reactions and reduced attention spans. , Now scientists at ... directly observed seizure-induced structural changes in brain cells in ...
Cached Medicine News:Health News:Study links hypertension in obese children to television viewing 2Health News:Video: Holiday Safety Is Important 2Health News:Merge Healthcare Provides Update on the Restatement of Its Financial Statements 2Health News:Merge Healthcare Provides Update on the Restatement of Its Financial Statements 3Health News:Merge Healthcare Provides Update on the Restatement of Its Financial Statements 4Health News:Merge Healthcare Provides Update on the Restatement of Its Financial Statements 5Health News:Majority of IsoTis Stockholders Vote for Integra Acquisition 2Health News:Epilepsy-induced brain cell damage prevented in the laboratory 2
Volume: 5 ml; Volume Graduation: 1/10 ml...
... AlphaForce fills 25ml pipette in ... fatest setting. Rechargeable during use. ... all with variable speed including ... Autoclavable pipette holder. Low battery ...
Inquire...
A convenient, rotating standholds up to seven Gilson pipettes (any model) with exceptional stability. Protects your precious pipettes from possible damage or contamination....
Medicine Products: